A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.
Share:
More In Business
Rebounder Founders: Can your Layoff Lead to Your Next Big Thing?
Can a layoff lead to your next big thing? Issie Lapowsky, contributor for Inc. Magazine and Alphonzo Terrell, co-founder and CEO of Spill join us to discuss.
Can't Decide What To Drink? This AI Robot Bartender Will Choose For You
Meet Scorpion, the latest, Nvidia-powered service robot from Richtech Robotics which crafts personalized cocktails and wine selections based on your mood
Big Business This Week: Back to the Office, Everyone!
Starbucks' new CEO unveils his plan for the future. Plus: Cable in the age of cord-cutting; AI vs. Meta, Microsoft, and Alphabet; and Elon's World.
Why Home Sales Are Worse Than Ever
Gina Heeb, finance reporter at The Wall Street Journal, joins us to discuss the current state of the real estate market and when things may turn around. Watch!
Find Out What One Expert Claims 'Is My Favorite Thing Apple Has Released This Year'
Managing Editor at Tom's Guide, Kate Kozuch, joins Cheddar to explain how Apple's AirPods now work as hearing aids and what she thinks of Apple Intelligence.
How One Man Experimented With A Wholesome Side Hustle on OnlyFans
Andrew Rummer joins Cheddar to discuss his experiment setting up an OnlyFans account with more wholesome content than others. Watch!
Big Business This Week: Bad Times for Starbucks, But IMF ❤️ USA
Plus, Stellantis is introducing EVs with crazy long battery power next year!
Ingram Micro Goes Public - What to Know
Ingram Micro went public today for the second time. Chief Financial Officer, Michael Zilis joins Cheddar's Dave Briggs to discuss the public offering.
Are Influencers Taking Over The Marketing Space?
Co-founder and CEO of Rad Intel, Jeremy Barnett, joins Cheddar anchor Dave Briggs to discuss the influencer marketing space and how RAD is changing the game.
